<DOC>
	<DOCNO>NCT00350194</DOCNO>
	<brief_summary>The purpose study determine effect omega-3 fatty acid form fish oil supplementation ( approximately 2 gram per day ) carotid intima-media ( CIMT ) progression ( primary objective ) 2 ) ( Secondary objective ) lipid marker LDL , apo-B , LDL buoyancy , inflammatory burden measure CRP , oxidative stress measure urinary isoprostanes , urine microalbumin/creatinine , serum adiponectin fat derive hormone subject metabolic syndrome .</brief_summary>
	<brief_title>The Effects Omega-3 Fatty Acids Metabolic Syndrome</brief_title>
	<detailed_description>This translational pilot study double-blind , placebo-controlled , parallel design . We enroll one hundred subject meet least 3 5 criterion metabolic syndrome per NCEP guidelines/WHO guideline know cardiovascular disease diabetes . They receive either placebo omega-3 fatty acid form fish oil capsule two-year period . Assessment , C-IMT , serum lipoprotein profile , LDL- buoyancy , adiponectin , CRP , SAA , apolipoprotein B A-1 , fast glucose , fast insulin level , plasma fatty acid measure baseline , one year , two year .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Adults Metabolic Syndrome ( meet 3 follow 5 ) Abdominal obesity , waist circumference men great 40 . &amp; woman great 35 . Serum triglycerides great = 150 mg/dL ( 1.7 mmol/L ) Serum HDL cholesterol less = 40 mg/dL men le 50 mg/dL woman Blood pressure great = 130/85 mmHg drug treatment elevate blood pressure Fasting plasma glucose great 100 mg/dL Diabetes Known document CHD ( include ECG consistent prior MI ) , CVA ( include TIA ) , PVD ( include symptom claudication ) Angina chest pain may indicate CHD Clinically significant neoplastic , cardiovascular , hepatic , renal , metabolic , endocrine ( untreated unstable ) , psychiatric ( untreated unstable ) Known abnormal LFTS great 2X ULN Smoker , illicit drug use , excessive alcohol use Medications : Lipid lower therapy , daily NSAID great 325 mg ASA ( PRN use ok ) , clopidogrel ( equivalent ) , Coumadin , Omega3 fatty acid supplement , investigational drug within 30 day study entry , high omega3 fatty acid content diet within past three month Pregnancy plan pregnancy study period Sensitivity allergy fish</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Fatty Acids , Omega-3</keyword>
</DOC>